Biomarkers for PTSD

Abstract

It is estimated that 10% to 20% of warfighters who have served in Iraq and Afghanistan have PTSD 1-4. An important limitation of these estimates is the reliance on self-report screening measures and clinical interviews to make the diagnosis of PTSD. These methods are subject to a number of biases, including underreporting of PTSD symptoms because of stigma of mental illness and concerns about adverse effects on careers, and exaggeration of symptoms in those seeking compensation for service- connected disability. Development of biomarkers of PTSD is critical for DOD and VA as objective indicators of PTSD for use in post-deployment medical screening, treatment selection, treatment outcome monitoring, disability evaluations, and for informing novel targets for treatment development.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jul 01, 2014
Accession Number
ADA619444

Entities

People

  • Charles R. Marmar

Organizations

  • New York University

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Anxiety Disorders
  • Biological Markers
  • Blood Proteins
  • Brain
  • Chemistry
  • Computational Biology
  • Data Mining
  • Genetics
  • Health Services
  • Information Science
  • Medical Personnel
  • Neuroimaging
  • Neurosciences
  • Psychiatry
  • Traumatic Stress Disorder

Fields of Study

  • Psychology

Readers

  • Gulf War Illness and Chronic Multisymptom Illness in Veterans.
  • Psychological Intervention/Treatment for Stress, Anxiety, PTSD, and Related Emotional and Cognitive Health Symptoms.
  • Rehabilitation and Prosthetic Care for Military Service Members and Veterans with Limb Loss or Disability.